BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22388628)

  • 1. Somatostatin receptor SPECT.
    Pepe G; Moncayo R; Bombardieri E; Chiti A
    Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S41-51. PubMed ID: 22388628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-photon emission computed tomography tracers in the diagnostics of neuroendocrine tumors.
    Pepe G; Bombardieri E; Lorenzoni A; Chiti A
    PET Clin; 2014 Jan; 9(1):11-26. PubMed ID: 25029930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor imaging and therapy using radiolabeled somatostatin analogues.
    de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP
    Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide receptor imaging and therapy.
    Kwekkeboom D; Krenning EP; de Jong M
    J Nucl Med; 2000 Oct; 41(10):1704-13. PubMed ID: 11038002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine tumors and somatostatin: imaging techniques.
    de Herder WW; Kwekkeboom DJ; Valkema R; Feelders RA; van Aken MO; Lamberts SW; van der Lely AJ; Krenning EP
    J Endocrinol Invest; 2005; 28(11 Suppl International):132-6. PubMed ID: 16625862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of neuroendocrine tumors.
    Rufini V; Calcagni ML; Baum RP
    Semin Nucl Med; 2006 Jul; 36(3):228-47. PubMed ID: 16762613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten years of experience with MIBG applications and the potential of new radiolabeled peptides: a personal overview and concluding remarks.
    Shapiro B
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):150-5. PubMed ID: 9002776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin receptor imaging for neuroendocrine tumors.
    de Herder WW; Kwekkeboom DJ; Feelders RA; van Aken MO; Lamberts SW; van der Lely AJ; Krenning EP
    Pituitary; 2006; 9(3):243-8. PubMed ID: 17001462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of neuroendocrine gastro-entero-pancreatic tumours using radiolabelled somatostatin analogues.
    Chiti A; van Graafeiland BJ; Savelli G; Ferrari L; Seregni E; Castellani MR; Bombardieri E
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S190-4. PubMed ID: 10604128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin receptor scintigraphy during treatment with lanreotide in patients with neuroendocrine tumors.
    Janson ET; Kälkner KM; Eriksson B; Westlin JE; Oberg K
    Nucl Med Biol; 1999 Nov; 26(8):877-82. PubMed ID: 10708300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The scintigraphy of somatostatin receptors in the carcinoid tumor].
    Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F
    Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumors.
    Janson ET; Westlin JE; Ohrvall U; Oberg K; Lukinius A
    J Nucl Med; 2000 Sep; 41(9):1514-8. PubMed ID: 10994731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours.
    Gotthardt M; Béhé MP; Grass J; Bauhofer A; Rinke A; Schipper ML; Kalinowski M; Arnold R; Oyen WJ; Behr TM
    Endocr Relat Cancer; 2006 Dec; 13(4):1203-11. PubMed ID: 17158765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, preparation and biological evaluation of a
    Behnammanesh H; Jokar S; Erfani M; Geramifar P; Sabzevari O; Amini M; Mazidi SM; Hajiramezanali M; Beiki D
    Bioorg Chem; 2020 Jan; 94():103381. PubMed ID: 31662215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.
    Kwekkeboom DJ; Kam BL; van Essen M; Teunissen JJ; van Eijck CH; Valkema R; de Jong M; de Herder WW; Krenning EP
    Endocr Relat Cancer; 2010 Mar; 17(1):R53-73. PubMed ID: 19995807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide imaging with somatostatin analogues: more than cancer probes.
    Cascini GL; Cuccurullo V; Tamburrini O; Rotondo A; Mansi L
    Curr Radiopharm; 2013 Mar; 6(1):36-40. PubMed ID: 23470033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radio-guided surgery in neuroendocrine tumors.
    Gulec SA; Baum R
    J Surg Oncol; 2007 Sep; 96(4):309-15. PubMed ID: 17726664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of somatostatin analogs in the treatment of neuroendocrine tumours].
    Cuccurullo V; Cascini GL; Rambaldi PF; Mansi L
    Minerva Endocrinol; 2001 Sep; 26(3):135-43. PubMed ID: 11753236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of somatostatin receptor scintigraphy in the detection of occult primary gastro-entero-pancreatic (GEP) neuroendocrine tumours.
    Savelli G; Lucignani G; Seregni E; Marchianò A; Serafini G; Aliberti G; Villano C; Maccauro M; Bombardieri E
    Nucl Med Commun; 2004 May; 25(5):445-9. PubMed ID: 15100502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State of the Art and Recent Developments of Radiopharmaceuticals for Pancreatic Neuroendocrine Tumors Imaging.
    Carollo A; Papi S; Grana CM; Mansi L; Chinol M
    Curr Radiopharm; 2019; 12(2):107-125. PubMed ID: 30843499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.